US Stock MarketDetailed Quotes

CRVS Corvus Pharmaceuticals

Watchlist
  • 1.450
  • -0.030-2.03%
Close Apr 26 16:00 ET
  • 1.450
  • 0.0000.00%
Post 18:44 ET
71.11MMarket Cap-2589P/E (TTM)

Corvus Pharmaceuticals Key Stats

Corvus Pharmaceuticals Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

Mar 19, 2024

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.13

+38.10%

Buy

Mar 31, 2024

Corvus Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 0.000--
--2024/Q1-- / 0.000--
Mar 19, 20242023/Q40.000 / 0.000--
Nov 7, 20232023/Q30.000 / 0.000--
Aug 8, 20232023/Q20.000 / 0.000--
May 8, 20232023/Q10.000 / 0.000--
Mar 28, 20232022/Q40.000 / 0.000--
Nov 3, 20222022/Q30.000 / 0.000--
Aug 8, 20222022/Q20.000 / 0.000--
--2022/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 0.000--
--2024/Q1-- / 0.000--
Mar 19, 20242023/Q40.000 / 0.000--
Nov 7, 20232023/Q30.000 / 0.000--
Aug 8, 20232023/Q20.000 / 0.000--
May 8, 20232023/Q10.000 / 0.000--
Mar 28, 20232022/Q40.000 / 0.000--
Nov 3, 20222022/Q30.000 / 0.000--
Aug 8, 20222022/Q20.000 / 0.000--
--2022/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Corvus Pharmaceuticals Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Mar 31, 2024

Buy

  • Buy

    50.00%
  • Hold

    50.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg